knowledge -WSS

knowledge

author：entertainment 2025-10-02 14:03:19 - browse：12

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Reporting on presidential health from Reagan to Trump and Biden

WSS

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Flagship Pioneering startup Sonata Therapeutics lays off 21

Readout Newsletter: CAR

Abridge raises $150m as clinical notes automation market heats up

Change Healthcare outage fallout shows need for new oversight

Male and female sex labels in research insufficient, scientists say

explore

knowledge

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

How to save health care price transparency rules

United colonoscopy coverage change 'may cost lives,' doctors say

Flagship Pioneering startup Sonata Therapeutics lays off 21

The cancer drug shortage isn’t new — and neither are the solutions

HHS secretary Becerra pressed on Change HealthCare cyberattack

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

RaDonda Vaught links Vanderbilt hospital issues to patient death

In age of alternative facts, a scholarly course on calling out crap

Abridge raises $150m as clinical notes automation market heats up

leisure time

Male and female sex labels in research insufficient, scientists say

Boston's new lab space is opening empty

Reporting on presidential health from Reagan to Trump and Biden

In 'major milestone,' FDA approves first cell therapy for solid tumors

Pushing for an NIH office for post

Change Healthcare outage fallout shows need for new oversight

knowledge

knowledge

explore

leisure time